B. Braun Medical Receives FDA Approval for Introcan Security® 2 Deep Entry IV Catheter – The Journal of Healthcare Contracting

B. Braun Medical Receives FDA Approval for Introcan Security® 2 Deep Entry IV Catheter – The Journal of Healthcare Contracting



October 11, 2024 – B. Braun Medical Inc. (B. Braun) introduced that the U.S. Meals and Drug Administration (FDA) has granted 510(okay) clearance for the Introcan Security® 2 Deep Entry IV Catheter, the newest addition to the Introcan Security 2 IV catheter portfolio.

The Introcan Security 2 Deep Entry IV catheter combines the trusted applied sciences of the unique Introcan Security 2 Multi-Entry and Introcan Security Deep Entry catheters, offering physicians with a sophisticated resolution that mixes the strengths of each units. This revolutionary catheter supplies absolutely automated passive security safety towards needle sticks and blood monitoring with a number of accesses in longer lengths and is designed to entry deeper veins in sufferers with tough vascular entry and to attain longer dwell occasions.

The Introcan Security Deep Entry IV Catheter has been proven to considerably improve PIVC residence time to roughly 5.7 days – in comparison with 3.8 days for traditional lengthy PIVCs – to assist scale back PIVC restart and escalation to dearer, invasive units reminiscent of peripherally inserted central PIVCs. catheters (PICC).

Extra data

Leave a Reply

Your email address will not be published. Required fields are marked *